Enmetazobactam
Enmetazobactam is an antibiotic adjuvant drug which acts as a beta-lactamase inhibitor, preventing the breakdown of other antibiotic drugs.
Enmetazobactam was invented by a team of scientists at Orchid Pharma in India and then out-licensed to Allecra Therapeutics for further development. In the United States and European Union, enmetazobactam is approved for use in the combination cefepime/enmetazobactam.